Background: Olfactory training is the only evidence-based treatment for post-viral olfactory
dysfunction. Smell disorders after SARS-CoV-2 infection have been attributed to …

Abstract Background Coronavirus disease 2019 (COVID-19) often causes chemosensory
impairment, and olfactory dysfunctions may have negative consequences on psychological …

Purpose of review To provide a detailed overview of the assessment of COVID-19-related
olfactory dysfunction and its association with psychological, neuropsychiatric, and cognitive …

Objective A novel COVID‐19 therapeutic, nirmatrelvir/ritonavir (Paxlovid), is commonly
associated with reports of dysgeusia. The Food and Drug Administration Adverse Event …

Chemosensory systems are deemed marginal in human pathology. In appraising their role,
we aim at suggesting a paradigm shift based on the available clinical and experimental data …

Olfactory and gustatory dysfunctions (OD, GD) are prevalent symptoms following COVID-19
and persist in 6%–44% of individuals post-infection. As only few reports have described their …

Background Heavy alcohol consumption-associated chemosensory dysfunction is
understudied, and early detection can help predict disease-associated comorbidities …

Background/aims: Quantitative and qualitative alterations in the sense of smell are well
established symptoms of COVID-19. Some reports have shown that non-neuronal …

The COVID-19 pandemic brought attention to our limited understanding of human olfactory
physiology. While the cellular composition of the human olfactory epithelium is similar to that …

Transient loss of smell is a common symptom of influenza and other upper respiratory
infections. Loss of taste is possible but rare with these illnesses, and patient reports of 'taste …